Concepts (97)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Infant, Premature | 4 | 2007 | 290 | 0.580 |
Why?
|
| Enterocolitis, Pseudomembranous | 7 | 1998 | 52 | 0.550 |
Why?
|
| Platelet Activating Factor | 7 | 1998 | 53 | 0.540 |
Why?
|
| Developmental Disabilities | 2 | 2007 | 195 | 0.310 |
Why?
|
| Nonlinear Dynamics | 1 | 2006 | 73 | 0.270 |
Why?
|
| Prenatal Care | 1 | 2005 | 72 | 0.260 |
Why?
|
| Infant, Newborn | 11 | 2009 | 2380 | 0.250 |
Why?
|
| Counseling | 1 | 2005 | 145 | 0.240 |
Why?
|
| Fetal Membranes, Premature Rupture | 1 | 2004 | 18 | 0.240 |
Why?
|
| Intestines | 5 | 1998 | 411 | 0.220 |
Why?
|
| Models, Neurological | 1 | 2006 | 405 | 0.220 |
Why?
|
| Parents | 1 | 2005 | 272 | 0.220 |
Why?
|
| Pregnancy Outcome | 1 | 2004 | 247 | 0.210 |
Why?
|
| Nitric Oxide | 2 | 1994 | 278 | 0.210 |
Why?
|
| Brain | 2 | 2007 | 2216 | 0.170 |
Why?
|
| High-Frequency Jet Ventilation | 1 | 1998 | 3 | 0.170 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 1998 | 54 | 0.160 |
Why?
|
| Hypoxia | 3 | 1998 | 641 | 0.110 |
Why?
|
| Enteral Nutrition | 1 | 1993 | 102 | 0.110 |
Why?
|
| Neonatal Abstinence Syndrome | 1 | 2009 | 6 | 0.090 |
Why?
|
| Adrenergic alpha-Agonists | 1 | 2009 | 34 | 0.090 |
Why?
|
| Clonidine | 1 | 2009 | 37 | 0.090 |
Why?
|
| Infant Mortality | 2 | 2004 | 59 | 0.090 |
Why?
|
| Pregnancy | 2 | 2005 | 2894 | 0.080 |
Why?
|
| Gestational Age | 2 | 2009 | 311 | 0.080 |
Why?
|
| Leukomalacia, Periventricular | 1 | 2007 | 18 | 0.070 |
Why?
|
| Motor Skills Disorders | 1 | 2007 | 15 | 0.070 |
Why?
|
| Fetal Development | 1 | 2006 | 30 | 0.070 |
Why?
|
| Fetal Viability | 1 | 2005 | 9 | 0.070 |
Why?
|
| Infant, Very Low Birth Weight | 1 | 2005 | 52 | 0.070 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2007 | 294 | 0.060 |
Why?
|
| Pregnancy, Multiple | 1 | 2004 | 37 | 0.060 |
Why?
|
| Fetal Death | 1 | 2004 | 56 | 0.060 |
Why?
|
| NG-Nitroarginine Methyl Ester | 2 | 1994 | 45 | 0.060 |
Why?
|
| Peroxidase | 2 | 1994 | 51 | 0.060 |
Why?
|
| Arginine | 2 | 1994 | 136 | 0.060 |
Why?
|
| Delivery, Obstetric | 1 | 2004 | 112 | 0.060 |
Why?
|
| Humans | 12 | 2009 | 86644 | 0.050 |
Why?
|
| Rats, Sprague-Dawley | 3 | 1995 | 1219 | 0.050 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 1998 | 683 | 0.050 |
Why?
|
| Rats | 5 | 1998 | 3990 | 0.050 |
Why?
|
| Length of Stay | 1 | 2004 | 702 | 0.050 |
Why?
|
| Databases, Factual | 1 | 2004 | 814 | 0.050 |
Why?
|
| Necrosis | 3 | 1998 | 204 | 0.050 |
Why?
|
| Prognosis | 1 | 2005 | 3679 | 0.040 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 1998 | 115 | 0.040 |
Why?
|
| Endotoxins | 2 | 1995 | 36 | 0.040 |
Why?
|
| Enterocolitis, Necrotizing | 1 | 1998 | 78 | 0.040 |
Why?
|
| Receptors, Cell Surface | 1 | 1998 | 286 | 0.040 |
Why?
|
| Time Factors | 1 | 2004 | 5210 | 0.030 |
Why?
|
| Bacterial Toxins | 1 | 1995 | 111 | 0.030 |
Why?
|
| Endothelins | 1 | 1994 | 35 | 0.030 |
Why?
|
| omega-N-Methylarginine | 1 | 1994 | 17 | 0.030 |
Why?
|
| Infant | 2 | 2007 | 3047 | 0.030 |
Why?
|
| Animals | 6 | 1998 | 26582 | 0.030 |
Why?
|
| Mesenteric Artery, Superior | 1 | 1993 | 19 | 0.030 |
Why?
|
| Hematocrit | 1 | 1993 | 68 | 0.030 |
Why?
|
| Female | 3 | 2009 | 44533 | 0.030 |
Why?
|
| Superoxides | 1 | 1993 | 73 | 0.030 |
Why?
|
| Disease Models, Animal | 3 | 1998 | 2232 | 0.030 |
Why?
|
| Infant, Premature, Diseases | 1 | 1994 | 78 | 0.030 |
Why?
|
| Regional Blood Flow | 1 | 1993 | 197 | 0.030 |
Why?
|
| Acetyltransferases | 1 | 1993 | 29 | 0.030 |
Why?
|
| Immunoglobulins | 1 | 1993 | 148 | 0.030 |
Why?
|
| Adrenal Cortex Hormones | 1 | 1993 | 263 | 0.030 |
Why?
|
| Neutrophils | 1 | 1993 | 307 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2009 | 7993 | 0.030 |
Why?
|
| Drug Therapy, Combination | 2 | 2009 | 894 | 0.030 |
Why?
|
| Risk Factors | 2 | 1998 | 5417 | 0.020 |
Why?
|
| Inflammation | 1 | 1994 | 920 | 0.020 |
Why?
|
| Hypnotics and Sedatives | 1 | 2009 | 125 | 0.020 |
Why?
|
| Aging | 1 | 1993 | 691 | 0.020 |
Why?
|
| Blood Pressure | 1 | 1993 | 1143 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2009 | 684 | 0.020 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2007 | 31 | 0.020 |
Why?
|
| Male | 4 | 2009 | 40966 | 0.020 |
Why?
|
| Hypoxia, Brain | 1 | 2007 | 41 | 0.020 |
Why?
|
| Adult | 1 | 2004 | 25648 | 0.020 |
Why?
|
| Prospective Studies | 1 | 1993 | 4214 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2009 | 1801 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2007 | 1673 | 0.010 |
Why?
|
| Azepines | 1 | 1998 | 20 | 0.010 |
Why?
|
| Platelet Membrane Glycoproteins | 1 | 1998 | 17 | 0.010 |
Why?
|
| Food, Formulated | 1 | 1998 | 24 | 0.010 |
Why?
|
| Triazoles | 1 | 1998 | 96 | 0.010 |
Why?
|
| Drug Synergism | 1 | 1998 | 303 | 0.010 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 1998 | 134 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 1998 | 510 | 0.010 |
Why?
|
| Lipopolysaccharides | 1 | 1998 | 286 | 0.010 |
Why?
|
| Neomycin | 1 | 1995 | 7 | 0.010 |
Why?
|
| Polymyxin B | 1 | 1995 | 4 | 0.010 |
Why?
|
| Metronidazole | 1 | 1995 | 26 | 0.010 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 1995 | 74 | 0.010 |
Why?
|
| Shock | 1 | 1995 | 42 | 0.010 |
Why?
|
| NF-kappa B | 1 | 1998 | 444 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 1995 | 912 | 0.010 |
Why?
|
| Mice | 2 | 1998 | 11352 | 0.010 |
Why?
|